Search Results for "Micrus Endovascular Merger"

00:46 EDT 3rd September 2014 | BioPortfolio

Original Source: Micrus Endovascular Corporation

Micrus develops, manufactures and markets implantable and disposable medical devices for use in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists, interventional neurologists and endovascularly trained neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic stroke and intracranial atherosclerosis, which may lead to ischemic stroke. Hemorrhagic and ischemic stroke are both significant c...

Matching Channels

Jobs in Endovascular


Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...

Boston Scientific

Boston Scientific is a global medical device company, the 8th largest (based on annual sales, which were over $8 billion in 2010). It is the world's second largest maker of heart devices; prod...

Matching News

Lombard Medical showcases Aorfix Endovascular Stent Graft at SVS Annual Meeting

Lombard Medical, Inc., a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAA), showcased its Aorfix Endovascular Stent Graft at the 2014 Society for ...

Nellix® EndoVascular Aneurysm Sealing System for abdominal aortic aneurysm repair

The Nellix® EndoVascular Aneurysm Sealing System (EVAS) has been developed by Endologix, Inc. for the endovascular repair of infrarenal abdominal aortic aneurysms (AAA). The system is designed to com...

FDA approves EKOS’ EkoSonic endovascular system

EKOS, a BTG International group company, has received approval from the US Food and Drug Administration (FDA) for its EkoSonic endovascular system to treat pulmonary embolism.

[Comment] Endovascular treatment for stroke: when does the window for good outcome close?

The mantra of stroke therapy (time is brain) is underscored once more in The Lancet Neurology in Pooja Khatri and colleagues' analysis of the IMS III study. The primary finding of the IMS III trial wa...

Game Changer for Endovascular Treatment of Ischemic Stroke?

Studies have failed to provide evidence that endovascular treatment is superior to medical treatment of acute ischemic stroke, but new devices and techniques may change that. Journal of Neurointerve...

Are Questcor Shareholders Getting A Good Deal?

ByIAEResearch:In April, Questcor (NASDAQ:QCOR) announced a merger with Mallinckrodt (NYSE:MNK) - effectively, Mallinckrodt will buy Questcor and absorb its product - Mallinckrodt shareholders will rem...

Early phase CROs may suffer from the aftereffects of a mega-merger, CEO says

As the Pfizer-AstraZeneca mega-merger seems to be pushing towards a deal, early phase CROs may be the first to suffer for a short period of time directly after the merger is complete.

ArtVentive Medical announces new catheter-assisted endovascular tumor treatment system

ArtVentive Medical has announced that the company is expanding its product portfolio to include a unique and proprietary Catheter-Assisted Endovascular Tumor Treatment (CAETT) system to deliver drugs ...

Matching PubMed Articles

Commentary: Endovascular Treatment for Buttock Claudication: The Proof of the Pudding Is in the Eating!

Endovascular treatment of intracranial aneurysms: diversity in treatment techniques of varying anatomical presentations.

We discuss and illustrate various endovascular treatment options for intracranial aneurysms, to reflect common technique used in endovascular treatment of brain aneurysm. We select five cases of vario...

Success Factors in Merging Teaching Hospitals.

Merger has served as a major strategy for the leaders of academic medical centers (i.e., teaching hospitals) who are pursuing health system development for their institutions. Applying hindsight to th...

Commentary: Endovascular Treatment of Persistent Sciatic Artery Aneurysm With the Multilayer Stent: Is It a Miraculous Solution for All Complex Conditions?

Commentary: Endovascular Therapy for Intermittent Claudication: Is It Time for Re-evaluation?

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement